Skip to main content
. 2017 Nov 3;12(11):e0187446. doi: 10.1371/journal.pone.0187446

Table 1. Disease-related parameters—Estimated values and ranges used in sensitivity analysis.

Parameter Value Range Source/Comments
Transmission constant (T) 5.1 Calibrated to match incidence rates of first infection at 6, 12, 24, 36 months as reported by Gladstone[28]
Efficacy of kth (k = 1, 2, 3) natural infection against any future infection (γk) 0.39, 0.52, 0.67 Low: 0.29, 0.43, 0.59 High: 0.47, 0.59, 0.74 [28]
Decreased infectiousness of second infection 0.5 0.3, 0.7 [29, 30]
Decreased infectiousness of third, fourth infection 0.2 0, 0.4 [29, 30]
Mean duration of infection (days) 7 4, 10 [25, 31]
Probability that kth (k = 1, 2, 3, 4) infection will cause symptoms given no vaccination (αk) 0.413, 0.349, 0.235, 0.201 ± 50% [28]
Probability that symptoms of kth (k = 1, 2, 3, 4) infection will be severe[34]* if present (βk) 0.153, 0.221, 0.233, 0.167 ± 50% [28]
Probability of dying from severe* rotavirus given no formal treatment 0.061 0.0305, 0.1220 Calibrated to match 5-year Indian rotavirus mortality of 1/242 without vaccination[32]
Waning of protection of maternal antibodies Protection declines linearly from 100% to 0% between birth and 13 weeks of age [33]

* Severe infections are defined as those with a Vesikari score > = 11.